Clinical Trial Update: Phase 1-2 Study of ASTX660 in Subjects With Advanced Solid Tumors and Lymphomas [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for a Phase 1-2 study of ASTX660 in subjects with advanced solid tumors and lymphomas; recruitment status is ACTIVE_NOT_RECRUITING.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoma
• Solid Tumors

Drugs mentioned

• ASTX660

Snippet

Sponsor: Taiho Oncology, Inc. | Conditions: Solid Tumors, Lymphoma | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING